Publications
35
Citations
397
Est. group size
~5
Recurring co-author estimate
Active years
31
Publishing since 1995
Tyler J. Carpenter's research centers on the biology of uterine fibroids and related gynecological tissue conditions, examining molecular changes in myometrial (uterine muscle) cells, stem/progenitor cell markers, and gene expression differences linked to fibroid development. Additional work touches on endometrial cancer molecular markers, DNA methylation patterns, and racial disparities in fibroid biology, with some unrelated publications on exercise physiology and animal genetics. This research combines molecular biology, genomics, and transcriptomics to better understand benign and malignant reproductive tissue disorders.
Publication output has been variable but shows an increase in recent years, with a notable peak in 2023 followed by continued activity through 2025.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- The Human Myometrial Transcriptome and the DNA Methylome of Testosterone-treated Patients Resemble the Myometria from Fibroid Patients
Reproductive Sciences · 2025
- HMGA2 overexpression induces plasticity in myometrial cells and a transcriptomic profile more similar to that of uterine fibroids
F&S Science · 2024
- Unraveling the Molecular Landscape of Uterine Fibroids, Insights into <i>HMGA2</i> and Stem Cell Involvement
bioRxiv (Cold Spring Harbor Laboratory) · 2024
- Cysteine-rich intestinal protein 1 is a novel surface marker for human myometrial stem/progenitor cells
Communications Biology · 2023
- Cysteine-Rich Intestinal Protein 1 is a Novel Surface Marker for Myometrial Stem/Progenitor Cells
bioRxiv (Cold Spring Harbor Laboratory) · 2023
- Data from Nuclear PTEN Localization Contributes to DNA Damage Response in Endometrial Adenocarcinoma and Could Have a Diagnostic Benefit for Therapeutic Management of the Disease
2023
- Fig. S3 from Nuclear PTEN Localization Contributes to DNA Damage Response in Endometrial Adenocarcinoma and Could Have a Diagnostic Benefit for Therapeutic Management of the Disease
2023
- Fig. S4 from Nuclear PTEN Localization Contributes to DNA Damage Response in Endometrial Adenocarcinoma and Could Have a Diagnostic Benefit for Therapeutic Management of the Disease
2023
- Fig. S1 from Nuclear PTEN Localization Contributes to DNA Damage Response in Endometrial Adenocarcinoma and Could Have a Diagnostic Benefit for Therapeutic Management of the Disease
2023
- Fig. S2 from Nuclear PTEN Localization Contributes to DNA Damage Response in Endometrial Adenocarcinoma and Could Have a Diagnostic Benefit for Therapeutic Management of the Disease
2023
- Fig. S3 from Nuclear PTEN Localization Contributes to DNA Damage Response in Endometrial Adenocarcinoma and Could Have a Diagnostic Benefit for Therapeutic Management of the Disease
2023
- Fig. S1 from Nuclear PTEN Localization Contributes to DNA Damage Response in Endometrial Adenocarcinoma and Could Have a Diagnostic Benefit for Therapeutic Management of the Disease
2023
- Fig. S4 from Nuclear PTEN Localization Contributes to DNA Damage Response in Endometrial Adenocarcinoma and Could Have a Diagnostic Benefit for Therapeutic Management of the Disease
2023
- Fig. S2 from Nuclear PTEN Localization Contributes to DNA Damage Response in Endometrial Adenocarcinoma and Could Have a Diagnostic Benefit for Therapeutic Management of the Disease
2023
- Data from Nuclear PTEN Localization Contributes to DNA Damage Response in Endometrial Adenocarcinoma and Could Have a Diagnostic Benefit for Therapeutic Management of the Disease
2023
- The Journal of Strength and Conditioning Research×3
- Cell Reports×2
- bioRxiv (Cold Spring Harbor Laboratory)×2
- Agronomy Journal×1
- Human Reproduction×1
- Brianna VanNoy
Medicine · The Ohio State University
- Vanida A. Serna
Medicine · The Ohio State University
- P Urbina
Medicine · The Ohio State University
- Meenal Misal
Medicine · The Ohio State University
- Jee Hyun Park
Medicine · Purdue University West Lafayette
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile